RE: Gilead moving to a nebulised remdesivir21 Jan 2022 07:46
Xv, thanks for post perhaps another potential treatment but as the article states:
"It should be noted, however, that the results from these primate animal models may not be easily translatable to human subjects. The nature of this experiment allowed treatment to begin within a few hours after infection, which would be difficult to replicate in human clinical studies or real-world settings. Further refinement of the inhaled remdesivir formula is necessary to ensure effective and safe antiviral treatment in humans"
I am quietly waiting in the wings. As Elsol suggested in another thread this morning, Monday "Meteoric Monday" would be a great day fir the big RNS, with JVT following news up on the same evening.
That would help hold any initial price rise spike up !!
Regards all.